Recombinant tumor necrosis factor: its effect and its synergism with interferon-gamma on a variety of normal and transformed human cell lines
- PMID: 3089802
- DOI: 10.1016/0277-5379(86)90107-0
Recombinant tumor necrosis factor: its effect and its synergism with interferon-gamma on a variety of normal and transformed human cell lines
Abstract
Tumor Necrosis Factor (TNF), released by induced macrophages, causes tumor necrosis in animals, and preferentially kills transformed cells in vitro. Using pure, recombinant human TNF, we report here its cytotoxic action on several human transformed and non-transformed cell lines. Furthermore, remarkable synergism between TNF and interferon-gamma (IFN-gamma) was observed in a large number of human cell lines, especially breast, cervix and colon carcinomas. Some other human cell lines, not sensitive to TNF alone, became highly sensitive when IFN-gamma was present as well. We could not demonstrate a synergism between TNF and IFN-gamma on any of the lymphoma/leukemia cell lines tested. All normal human, non-transformed diploid cell lines were insensitive to TNF even in the presence of IFN-gamma. This study also confirms the observation that inhibition of protein synthesis by metabolic drugs (e.g. actinomycin D) remarkably enhances the sensitivity of several target cell lines to cytolysis by TNF.
Similar articles
-
Recombinant tumor necrosis factor: species specificity for a variety of human and murine transformed cell lines.Cell Immunol. 1986 Jun;100(1):260-7. doi: 10.1016/0008-8749(86)90025-0. Cell Immunol. 1986. PMID: 3091262
-
Inhibition of protein synthesis enhances the lytic effects of tumor necrosis factor alpha and interferon gamma in cell lines derived from gynecological malignancies.Cancer Immunol Immunother. 1991;33(3):183-8. doi: 10.1007/BF01756140. Cancer Immunol Immunother. 1991. PMID: 1904315 Free PMC article.
-
Antiproliferative effects exerted by recombinant human tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) on human pancreatic tumor cell lines.Pancreas. 1988;3(2):180-8. doi: 10.1097/00006676-198804000-00012. Pancreas. 1988. PMID: 3131759
-
Induction of receptors for tumor necrosis factor-alpha by interferons is not a major mechanism for their synergistic cytotoxic response.J Biol Chem. 1987 Jul 25;262(21):10000-7. J Biol Chem. 1987. PMID: 2440858
-
Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.Science. 1985 Nov 22;230(4728):943-5. doi: 10.1126/science.3933111. Science. 1985. PMID: 3933111
Cited by
-
Influence of intravesical administration of tumor necrosis factor alpha and systemic gamma-interferon on murine bladder cancer: lack of dose response.Urol Res. 1990;18(4):287-9. doi: 10.1007/BF00294775. Urol Res. 1990. PMID: 2120837
-
Induction and regulation of mRNA encoding 26-kDa protein in human cell lines treated with recombinant human tumor necrosis factor.Proc Natl Acad Sci U S A. 1987 Jul;84(13):4557-61. doi: 10.1073/pnas.84.13.4557. Proc Natl Acad Sci U S A. 1987. PMID: 3496595 Free PMC article.
-
Generation of a mouse tumor necrosis factor mutant with antiperitonitis and desensitization activities comparable to those of the wild type but with reduced systemic toxicity.Infect Immun. 1997 Jun;65(6):2006-10. doi: 10.1128/iai.65.6.2006-2010.1997. Infect Immun. 1997. PMID: 9169725 Free PMC article.
-
Growth and major histocompatibility antigen expression regulation by IL-4, interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) on human renal cell carcinoma.Clin Exp Immunol. 1994 Jun;96(3):476-83. doi: 10.1111/j.1365-2249.1994.tb06054.x. Clin Exp Immunol. 1994. PMID: 8004818 Free PMC article.
-
Telomerase and CD4 T Cell Immunity in Cancer.Cancers (Basel). 2020 Jun 25;12(6):1687. doi: 10.3390/cancers12061687. Cancers (Basel). 2020. PMID: 32630460 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources